Hims & Hers Health Inc. Stock News

Hims & Hers Health, Inc.'s stock dropped over 25% over the last 2 days due to Amazon's entry into the hair loss and ED markets, but I believe investor pessimism is overblown. Despite Amazon's competition, Hims & Hers's focus on personalized solutions, which saw 175% YoY growth, provides a strong competitive moat. Even with conservative growth estimates, Hims & Hers has a 38% upside potential, m...

Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock take a steep dive on Thursday, just after Amazon announced updates to a strikingly similar service for Prime members.

Amazon is now offering upfront pricing for virtual care for ailments such as men's hair loss and ED.

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits.

Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile dysfunction and men's hair loss. The move places the company in competition with other direct-to-consumer marketplaces like Hims & Hers Health and Ro.

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy.

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need. Hims & Hers has been collec...

The healthcare company is on fire, and it's still cheap by many measures.